1. Total hysterectomy of the uterine adnexa: Regular vulvar, vaginal and pelvic ultrasound. Patients may still have vulvar and vaginal lesions. Pelvic ultrasound can check the pelvic cavity and exclude pelvic fluid or pelvic masses formed by postoperative pelvic inflammation, etc. 2. Simple hysterectomy or hysterectomy and one side of adnexa: There are still one or both ovaries and fallopian tubes in the pelvis, which may still have lesions like normal people, so regular examinations related to ovarian tumors are needed, including routine gynecological examination, pelvic ultrasound and tumor markers (CA125125, CA199, CEA and APF) testing. Vaginal ultrasound examination every six months to a year can detect ovarian tumors early. 4.Sub-total hysterectomy: the cervix and bilateral adnexa are preserved. Regular gynecological examination, regular cervical cancer (HPV and TCT) screening and regular ultrasound examination are required after surgery to exclude ovarian pathology. 5.Patients who had hysterectomy because of gynecological malignant tumor should have regular postoperative follow-up according to the interval specified for that tumor. 6.Patients who underwent hysterectomy for precancerous lesions of the cervix: those who underwent hysterectomy without a history of CIN2+ can stop screening; those who have a history of CIN2+ can continue screening and follow-up until 20 years after diagnosis after hysterectomy. Some scholars believe that regardless of hysterectomy, as long as women still have sex, they may be infected with HPV and cause disease, and even stump cancer and vaginal cancer, so regular gynecological examination and stump screening are needed. 8. Younger women with hysterectomy and bilateral adnexal resection should pay attention to the problem of early menopause. Because of the steep postoperative hormonal decline, women who have menopause through surgical removal of the ovaries have more severe menopausal symptoms and are more likely to experience cardiovascular events and disorders of the vegetative nervous system. If there are no contraindications, sex hormone supplementation therapy is generally recommended under medical supervision to relieve menopausal symptoms and prevent bone loss and osteoporosis.